Health and Human Services Secretary Robert F. Kennedy Jr.
Keep Reading →
June 13 - News
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Keep Reading →
June 12 - Hedge Funds, News
The medication is being studied as a potential treatment for hyperlipidemia, a condition marked by high levels of fat in the bloodstream.
Keep Reading →
June 11 - News
The Dow Jones Industrial Average, often called the Dow Jones or just the Dow, is a stock market index that tracks 30 major publicly traded companies in the United States.
Keep Reading →
June 11 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S.
Keep Reading →
June 11 - News
A wide-moat stock is a company stock that maintains market leadership through a premium product, brand value, or corporate strategy.
Keep Reading →
June 10 - Hedge Funds, News
Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent program on CNBC and explained the potential risks and...
Keep Reading →
June 5 - News
A new clinical trial has shown that combining Gilead Sciences, Inc. (NASDAQ:GILD)’s Trodelvy with Merck & Co., Inc.
Keep Reading →
May 31 - News
Jim Cramer in a recent program on CNBC commented on Merck & Co Inc.
Keep Reading →
May 30 - News
Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
May 30 - Hedge Fund Investor Letters, News
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK.
Keep Reading →
May 21 - News, Stock Analysis
Chris Toomey, Morgan Stanley managing director of private wealth, said in a latest program on CNBC that he is not bullish on stocks yet and plans to “stay defensive” until...
Keep Reading →
May 19 - Hedge Funds, News
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
Keep Reading →
May 14 - Hedge Funds, News
Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages.
Keep Reading →
May 13 - Dividend Stocks, Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected to shift lower as and when the deals are made, supply chains...
Keep Reading →
May 10 - Hedge Funds, News
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Keep Reading →
May 10 - Dividend Stocks, Hedge Funds, News
The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US.
Keep Reading →
May 7 - News, Stock Analysis
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Keep Reading →
May 7 - News, Stock Analysis
Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed by a research-driven equity investment style.
Keep Reading →
May 6 - Hedge Funds, News
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Keep Reading →
May 3 - Hedge Funds, Industries, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the growing amount of stock buybacks and how the buybacks during April-May were the third best ...
Keep Reading →
April 30 - News
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
Keep Reading →
April 30 - Hedge Funds, Industries, News
Cliff Asness, the founder, managing principal, and chief investment officer of AQR Capital Management, is a well-known figure in the world of finance.
Keep Reading →
April 30 - Hedge Funds, News
Blue chip stocks are under immense pressure amid the evolving trade tensions and tariff announcements around the globe.
Keep Reading →
April 29 - Hedge Funds, News
“These are hideous depressing days for the bulls. I'm not used to seeing a White House that doesn't seem to care that it's causing the decline.
Keep Reading →
April 27 - Hedge Funds, News
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Keep Reading →
April 26 - Business, Hedge Funds, News
Blue chip stocks are large, financially stable companies with strong market presence, consistent profitability, and regular dividend payments.
Keep Reading →
April 26 - Hedge Funds, News
Operator: Thank you for standing by. Welcome to the Merck & Co., Inc., Rahway, New Jersey U.S.A. Quarter 1 Sales and Earnings Conference Call. This call is being recorded.
Keep Reading →
April 26 - News, Transcripts
Marjorie Taylor Greene is one of the most active members of the Trump administration on the US stock market.
Keep Reading →
April 23 - Insider Trading, News
Momentum and technology stocks have dominated the markets over the past decade.
Keep Reading →
April 22 - Hedge Funds, News
Trump's "stupid" tariffs will fail; that's the sentiment echoed by billionaire investor Ken Fisher as their impact continues to be felt far and wide.
Keep Reading →
April 18 - Hedge Funds, News
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
Keep Reading →
April 17 - Hedge Funds, News
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
Keep Reading →
April 16 - Hedge Funds, News
The stock market has been experiencing volatility and has quickly shifted from the post-election highs to being priced for recession.
Keep Reading →
April 16 - Hedge Funds, News
On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined 'The Exchange' on CNBC to discuss her thoughts on how good quality companies can ride out turbulence...
Keep Reading →
April 15 - Hedge Funds, News
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Keep Reading →
April 14 - Hedge Funds, News
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the market turmoil of the week and provided some valuable lessons.
Keep Reading →
April 11 - Hedge Funds, News
On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in a discussion on CNBC's 'Squawk Box'.
Keep Reading →
April 11 - Hedge Funds, News
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Keep Reading →
April 10 - Hedge Funds, Industries, News
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Keep Reading →
April 10 - News, Stock Analysis
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Keep Reading →
April 8 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer shared what the Trump administration could do to stop the stock market bloodbath unleashed by tariffs.
Keep Reading →
April 7 - News
On Monday, Jim Cramer, host of Mad Money, shared his thoughts on how the government's approach to tariffs could play a crucial role in sustaining the stock market rally.
Keep Reading →
March 25 - Hedge Funds, News
Billionaire Ken Fisher, a prominent money manager, renowned author, and financial analyst, is the founder of Fisher Asset Management.
Keep Reading →
March 24 - Hedge Funds, News
Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions revolving around the Federal Reserve, interest rates...
Keep Reading →
March 24 - Hedge Funds, News